Have a personal or library account? Click to login
The significance of a positive DAT in thalassemia patients Cover

The significance of a positive DAT in thalassemia patients

Immunohematology
Volume 26 (2010): Issue 3 (September 2010)
By: S.A. Arinsburg,  D.L. Skerrett,  D. Kleinert,  P.J. Giardina and  M.M. Cushing  
Paid access
|Mar 2020

Authors

S.A. Arinsburg

New York Blood Center/New York Presbyterian Hospital, Columbia University Medical Center, Department of Professional Education, New York, NY, United States

D.L. Skerrett

Transfusion Medicine and Cellular Therapy, New York, NY, United States

D. Kleinert

Nurse Practitioner, Thalassemia Program, New York, NY, United States

P.J. Giardina

Thalassemia Program, Transfusion Medicine and Cellular Therapy, New York-Presbyterian Hospital-Weill Cornell Medical College, Department of Pathology, New York, NY, United States

M.M. Cushing

Thalassemia Program, Transfusion Medicine and Cellular Therapy, New York-Presbyterian Hospital-Weill Cornell Medical College, Department of Pathology, New York, NY, United States
DOI: https://doi.org/10.21307/immunohematology-2019-207 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 87 - 91
Published on: Mar 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
DAT,
thalassemia,
RBC transfusions,
alloantibodies,
autoantibodies
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 S.A. Arinsburg, D.L. Skerrett, D. Kleinert, P.J. Giardina, M.M. Cushing, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 26 (2010): Issue 3 (September 2010)Next article